A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine
Background. Intrapartum single-dose (SD) nevirapine (NVP) reduces perinatal transmission of human immunodeficiency virus (HIV) infection but selects for NVP-resistant virus, which compromises subsequent NVP-based therapy. A 1-week "tail" of lamivudine and zidovudine after SD-NVP decreases...
محفوظ في:
المؤلفون الرئيسيون: | Russell B. Van Dyke, Nicole Ngo-Giang-Huong, David E. Shapiro, Lisa Frenkel, Paula Britto, Anuvat Roongpisuthipong, Ingrid A. Beck, Praparb Yuthavisuthi, Sinart Prommas, Thanyawee Puthanakit, Jullapong Achalapong, Nantasak Chotivanich, Wirawan Rasri, Tim R. Cressey, Robert Maupin, Mark Mirochnick, Gonzague Jourdain |
---|---|
التنسيق: | دورية |
منشور في: |
2018
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84555209220&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51949 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine
بواسطة: Russell B. Van Dyke, وآخرون
منشور في: (2018) -
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine
بواسطة: Van Dyke R., وآخرون
منشور في: (2017) -
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018) -
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018) -
Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine
بواسطة: Marc Lallemant, وآخرون
منشور في: (2018)